Recently it has been demonstrated that tissuemuscle fibers in a mild form of human muscular dystrospecific disruption of dystroglycan in the brain is suffiphy caused by disruption of posttranslational dystrocient to cause neuronal migration errors that closely glycan processing. Thus, maintenance of regenerative resemble the brain abnormalities seen in congenital capacity by satellite cells expressing dystroglycan is muscular dystrophy (Moore et al., 2002) . Moreover, we likely responsible for mild disease progression in mice have shown that mutations in glycosyltransferases and possibly humans. Therefore, inadequate repair of (POMGnT1, fukutin, and LARGE) result in posttranslaskeletal muscle by satellite cells represents an importional disruption of dystroglycan-ligand interactions in tant mechanism affecting the pathogenesis of muscuthe skeletal muscle of patients with a severe phenotype lar dystrophy.
of congenital muscular dystrophy . In order to better understand the function of dystroglyIntroduction can in mature, differentiated skeletal muscle, we have used the Cre-loxP system to specifically inactivate the Muscular dystrophies are a diverse group of inherited dystroglycan gene in skeletal muscle using the muscle disorders characterized by progressive muscle weakcreatine kinase (MCK) promoter in transgenic mice (Bruness and wasting (Bushby, 2000; Cohn and Campbell, ning et al., 1998). Mice with skeletal muscle-specific 2000). The dystrophin-glycoprotein complex (DGC) is disruption of dystroglycan (MCK-DG null) develop myoa multisubunit complex comprised of peripheral and necrosis around 4-6 weeks of age, indicating that loss integral membrane proteins, which links the cytoskeleof dystroglycan and accompanying disruption of the ton to the extracellular matrix. The proteins that com-DGC at the sarcolemma alone is sufficient to cause prise the DGC are the intracellular proteins (dystrophin muscular dystrophy. Given the previously demonstrated and the syntrophins) and the sarcolemmal proteins (dysfindings in functionally dystroglycan null patients and mice we were surprised to find that despite ongoing cycles of muscle degeneration, signs of fibrosis and fat replacement generally seen in other mouse models of muscular dystrophy. Instead, they present with a remarkably mild phenotype with signs of efficient muscle regeneration and marked skeletal muscle hypertrophy similar to findings observed in early stages of human and mouse models with muscular dystrophy.
Here we find that dystroglycan is expressed in satellite cells. During cycles of degeneration, satellite cells are repetitively activated in MCK-DG null mice. Because satellite cells have not been targeted by the MCK Cre promoter, this activation leads to expression of dystroglycan and other components of the DGC in muscle fibers undergoing regeneration. Our results reveal the first in vivo evidence that self-renewing potential does not necessarily decrease in aging mice undergoing repetitive cycles of de-and regeneration during the course of muscular dystrophy. Our findings provide new insights into the pathogenesis of muscular dystrophy by demonstrating that perturbation of satellite cell function leading to insufficient repair of skeletal muscle cells represents a major pathogenetic mechanism in the course of muscular dystrophy. littermates and grew normally. In a different breeding strategy, we generated mice heterozygous for the floxed gene and for the original dystroglycan knockout allele muscular junctions, suggesting that MCK-Cre either might not be active in myonuclei associated with these (L/Ϫ). These mice were then bred to MCK-Cre mice in order to obtain MCK-Cre/L/Ϫ mice. However, no differsites or that dystroglycan half-life and turnover might be different (not shown). The unexpected finding of skeletal muscle hypertrophy ␣2 was normal in MCK-DG null mice, which can most and morphological signs of muscle regeneration even likely be explained by normal sarcolemmal expression in 15-to 18-month-old MCK-DG null mice prompted levels of ␣7 integrin (data not shown), which serves as us to more closely investigate this phenomenon. One an additional receptor for laminin ␣2 in skeletal muscle.
Results

Generation of Dystroglycan (lox) Mice and Breeding Strategy
interesting observation we made during our analysis of Histological studies of various skeletal muscles, in-MCK-DG null mice was that clusters of dystroglycancluding quadriceps, gastrocnemius, tibialis anterior, bipositive muscle fibers were consistently present in older ceps, gluteus maximus, and diaphragm, displayed hismice. Therefore, we studied expression levels of dystological hallmarks of muscular dystrophy such as troglycan in MCK-DG null mice at various ages using myonecrosis, central nucleation, and variation of fiber an immunohistochemical approach. Remarkably, dyssize in MCK-DG null mice at around 6 weeks of age.
troglycan was expressed at normal levels in newborn Furthermore, significant elevation of serum creatine ki-MCK-DG null mice ( Figure 3A) . By around 4 weeks of nase was observed in these mice (Figure 1) . age, dystroglycan expression was nearly absent from the sarcolemma (fewer than 5% fibers were positive). In contrast, analysis of dystroglycan expression in MCK-MCK-DG Null Mice Develop Significant Skeletal Muscle Hypertrophy with Age DG null mice at numerous intervals between 10 weeks and 18 months of age revealed muscle fiber groups As MCK-DG null mice aged, we observed an interesting phenomenon. In marked contrast to other models of expressing dystroglycan with a frequency of dystroglycan-positive fibers of around 40% and 54%, respectively muscular dystrophy such as the dystrophin-deficient mdx mice or the sarcoglycan null mice, which show ( Figure 3A) . Dystroglycan-positive clusters were present only after the onset of the dystrophic process, which significant muscle atrophy at 12-18 months of life, MCK-DG null mice developed substantial hypertrophy of the began at about 6 weeks of age. These results led us to hypothesize that dystroglycan might be reexpressed skeletal muscle. As shown in Figure 2 and Table 1 , 15-month-old MCK-DG null mice were larger than littermate during regenerative cycles caused by the ongoing dystrophic process and that activated satellite cells or other controls only carrying the Cre transgene. Similar results were observed when MCK-DG null mice were compared myogenic precursor cells, which are not targeted by the MCK-Cre promoter, might initiate the expression of to age-matched homozygous dystroglycan-floxed mice (data not shown). Determination of wet muscle weights dystroglycan during the course of regeneration. Consequently, we analyzed frozen crosssections of showed widespread increase of muscle mass, particularly in the quadriceps and gastrocnemius muscles, skeletal muscle from wild-type and MCK-DG null mice for satellite cell expression of dystroglycan and M-cadhwhere the weight doubled (Table 1) . Histological evaluation of muscle fibers as well as the full diaphragm thickerin, a cell adhesion molecule that has been reported to 
MCK-DG Null Mice Maintain Their Regenerating
perturbed expression of the DGC, while regenerating myofibers in MCK-DG null mice expressed relatively norCapacity in Contrast to mdx and Sarcoglycan Null Mice mal DGC. In order to compare the regenerative capacity of MCKIn order to evaluate whether the dystrophin-glycoprotein complex might have an impact on muscle regeneration, DG null mice to dystrophin-deficient mdx mice and sarcoglycan null mice, we exposed 4-month-old and 15-we studied by immunohistochemistry the expression of DGC components in 4-month-old wild-type, MCK-DG month-old mice to calf injections of cardiotoxin and analyzed the phenotype 4 days and 14 days after injection null, mdx, and ␦-sarcoglycan null mice 4 days after cardiotoxin challenge. MCK-DG null mice showed exof the toxin. At 4 months of age, wild-type and MCK-DG null mice as well as mdx and ␦-sarcoglycan null mice pression levels that were similar to wild-type muscle of ␤-dystroglycan, ␣-sarcoglycan, ␤-sarcoglycan, utrophin, showed signs of effective regeneration, as assessed by the presence of small rounded muscle fibers with and dystrophin during regeneration ( Figure 5 ). In contrast, expression levels of DGC components were markcentrally located nuclei, a basophilic cytoplasm, and neonatal myosin immunoreactivity 4 days after injection edly abnormal in mdx and ␦-sarcoglycan null mice.
Although upregulation of utrophin in actively regener-(data not shown). Fourteen days after cardiotoxin injection, muscle architecture was largely restored, as demating muscle fibers does seem to partially compensate for the absence of dystrophin in mdx mice, expression onstrated by the presence of normal diameter and centrally nucleated myofibers in MCK-DG null, mdx, and levels for ␤-dystroglycan and the sarcoglycans decrease shortly (about 7-10 days) after the acute phase of ␦-sarcoglycan null mice (data not shown). In marked contrast, cardiotoxin challenge in 15-month-old mice regeneration ( Figure 5 ). Mice deficient for ␦-sarcoglycan apparently lack upregulation of a compensatory protein exhibited a difference between MCK-DG null mice on the one hand and mdx and ␦-sarcoglycan null mice on for the missing sarcoglycan; thus, no sarcoglycan expression was observed during the acute phase of musthe other. MCK-DG null mice showed signs of effective regeneration 4 days after cardiotoxin injection, whereas cle regeneration. Interestingly, analysis of dystrophin expression revealed that sarcolemmal localization of mdx mice and ␦-sarcoglycan null mice responded only poorly to the cardiotoxin-induced regeneration chaldystrophin is reduced in muscle fibers of ␦-sarcoglycan null mice 4 days after cardiotoxin injection. These data lenge ( Figure 5) . Interestingly, the regenerative response was less efficient in sarcoglycan null mice compared to indicate that the regeneration process in mdx and sarcoglycan null mice led to repopulation by myofibers with mdx mice. sources. This indicates considerable loss of dystroglyIn order to finally demonstrate that dystroglycan has can ligand binding activity in both muscle samples (Figan essential role in the biological function of satellite ure 7C). cells in vivo, we studied the effect of cardiotoxin on skeletal muscle regeneration in mice lacking dystroglycan at the sarcolemma of skeletal muscle as well as in Discussion satellite cells using MORE-DG null mice. MORE-DG null mice lack dystroglycan in all tissues in the embryo. HowSeveral forms of muscular dystrophy caused by mutations of components of the DGC have been identified during ever, dystroglycan is still expressed in extraembryonic membranes to circumvent embryonic lethality. Interestthe past two decades. However, we lack a clear understanding of the pathogenetic mechanism(s) responsible ingly, cardiotoxin challenge in MORE-DG null mice (2 weeks of age) revealed not only lack of reexpression of for the severe progressive and devastating course of these disorders. Current hypotheses developed through dystroglycan but also severely impaired regenerative response 4 and 7 days after toxin injection (see Supplemany years of research suggest two main biological cascades involved in the dystrophic disease process. mental Figure S2 at http://www.cell.com/cgi/content/ full/110/5/639/DC1), demonstrating that dystroglycan First, the DGC plays an essential role in protecting the sarcolemma against muscle contraction-induced injury, expression in satellite cells is essential for the regenerating capacity in skeletal muscle. and perturbation of the DGC causes sarcolemmal instability and structural damage subsequently leading to Morphological comparison of MCK-DG null, mdx, and ␦-sarcoglycan mice at 18 months of age (n ϭ 6 for each increased calcium influx followed by muscle cell death. Second, while skeletal muscle seems capable of effigroup), which have not been challenged by any toxin injections, demonstrated the development of significant ciently repairing itself during the early phase of the disease, it is believed that the ongoing stimulus and activaendomysial fibrosis and extensive replacement of muscle by adipose tissue in mdx and ␦-sarcoglycan null tion of the repair mechanism eventually exhaust the satellite cell pool. Consequently, failure of the myogenic mice (Figure 6) . In marked contrast, MCK-DG null mice and stability of the sarcolemma in skeletal muscle. However, our data elaborate on the second paradigm. We find that dystroglycan plays an essential role in satellite cell function by demonstrating that muscle-regenerating capacity can be sustained until senescence despite repetitive activation of degeneration/regeneration cycles, thereby preventing the development of severe tissue fibrosis and fat replacement. Thus, dysfunction of the satellite cell population leading to impairment of the repair mechanism in skeletal muscle represents a key mechanism in the pathogenesis of muscular dystrophy. (n ϭ 4). These data were analyzed statistically using Student's t test. 
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